Peptide Library
Knowledge · Peptide Library
Every compound we stock —plus the ones we don’t.
Filter by mechanism or by how much human evidence sits behind a compound. Reference profiles are included for compounds we have no intention of selling, because knowing what something is matters more than whether we happen to stock it.
5-Amino-1MQ 10 mg
Metabolic & Weight
Small-molecule NNMT inhibitor. All efficacy data is four mouse studies; no human trial of any NNMT inhibitor has ever been run.
Adipotide 10 mg
Metabolic & Weight
Prohibitin-targeting peptide that ablates white adipose vasculature; primate data only.
AICAR 50 mg
Metabolic & Weight
AMP analogue and direct AMPK activator; on the WADA list since 2009.
AOD-9604 5 mg
Metabolic & Weight
Six randomised placebo-controlled trials in ~900 obese adults. The pivotal 24-week study found no difference from placebo at any dose.
ARA-290 16 mg
Repair & Recovery
Non-haematopoietic erythropoietin mimetic; small-fibre neuropathy trials in sarcoidosis.
BPC-157 10 mg
Repair & Recovery
Gastric pentadecapeptide with an extensive rodent literature on tendon, gut and vascular repair.
Cagrilintide 5 / 10 mg
Metabolic & Weight
The 22.7% everyone quotes is CagriSema, not this. Cagrilintide on its own lost 11.5% in a 302-person phase 3 arm.
Cartalax 20 mg
Longevity & Mitochondrial
Sold for cartilage. One study has ever put it in contact with cartilage — in a dish, where the crude extract beat it. No human exposure on record.
Cerebrolysin 60 mg
Cognitive & Sleep
Peptide preparation used clinically in Europe and Asia for stroke and dementia.
CJC-1295 (No DAC) 10 mg
Growth Hormone Axis
Modified GRF(1-29). Every published CJC-1295 trial used the with-DAC conjugate, a different molecule; this form has no human data.
DSIP 10 mg
Cognitive & Sleep
Nonapeptide isolated from rabbit cerebral venous blood. Genuinely tested in controlled human sleep trials — and the best-designed one found no meaningful benefit.
Eloralintide 5 mg
Metabolic & Weight
Not cagrilintide, and not a GLP-1. A 263-person phase 2 lost 9% at the low end of its range and 20% at the top — and at the low end nausea came in below placebo.
Epitalon 10 mg
Longevity & Mitochondrial
Pineal tetrapeptide credited with the famous Russian mortality trials — which used a different substance.
FOXO4-DRI 10 mg
Longevity & Mitochondrial
Retro-inverso FOXO4 peptide that disrupts FOXO4-p53 interaction in senescent cells.
GHK-Cu 50 mg
Repair & Recovery
Copper-transport tripeptide with a real topical literature — and 15.8% of its mass is elemental copper.
GHRP-2 10 mg
Growth Hormone Axis
Approved in Japan as a one-hour diagnostic test at 100 µg. A 10 mg vial holds a hundred of those doses. On FDA's Category 2 list.
GHRP-6 10 mg
Growth Hormone Axis
The compound the class was built from, and the one FDA singled out. Five human studies, the longest 34 hours — and not one measured appetite.
GLOW 70 mg
Blends & Stacks
Three-component recovery and dermal blend; the components have very different evidence bases.
Glutathione 600 mg
Longevity & Mitochondrial
The cell's principal redox buffer — and the one compound here where injecting it is the worst-evidenced way to take it.
Gonadorelin 2 mg
Hormonal & Other
Strong evidence — all of it from a pump that pulses every 90 minutes. The way it is sold has never been studied.
Hexarelin 5 mg
Growth Hormone Axis
The only one in this class with human cardiac data in patients — and the effect fades as the heart gets sicker. A discontinued drug candidate.
IGF-1 LR3 1 mg
Growth Hormone Axis
Long-arginine-3 IGF-1 with reduced binding-protein affinity and extended half-life.
Ipamorelin 10 mg
Growth Hormone Axis
Ghrelin-receptor agonist. The selectivity data everyone quotes come from rats and pigs; the one human efficacy trial was negative.
Kisspeptin-10 10 mg
Hormonal & Other
Upstream regulator of GnRH release; substantial Imperial College human trial programme.
KLOW 80 mg
Blends & Stacks
All four components named by Health Canada. 62.5% of the vial by mass is a copper complex — 7.91 mg of elemental copper.
KPV 10 mg
Immune & Anti-inflammatory
Genuinely melanocortin-receptor-independent — but its best evidence is oral, through a gut transporter.
Livagen 20 mg
Longevity & Mitochondrial
Lysyl-glutamyl-aspartyl-alanine; chromatin decondensation research.
LL-37 5 mg
Immune & Anti-inflammatory
Your own neutrophils make it. Three randomised topical trials; the 148-patient one missed its primary endpoint. The same molecule causes the inflammation in rosacea.
Mazdutide 10 mg
Metabolic & Weight
Approved in China at 4 and 6 mg. The −16.7% everyone quotes is the 9 mg dose, which is approved nowhere.
Melanotan II 10 mg
Hormonal & Other
Non-selective melanocortin receptor agonist; MC1R pigmentation and MC4R behavioural effects.
MGF 5 mg
Growth Hormone Axis
IGF-1Ec splice variant expressed by mechanically loaded muscle.
MOTS-c 10 mg
Metabolic & Weight
Encoded in your own mitochondrial DNA. The human studies measured it — none gave it.
NAD+ 1000 mg
Longevity & Mitochondrial
Cells do not import finished NAD+ — an enzyme on the outside of the membrane takes it apart first. Named by Health Canada in April 2026.
Oxytocin 10 mg
Cognitive & Sleep
Licensed since 1981 for labour induction, dosed in nanograms per minute. The social literature failed its replications, and the largest autism trial moved the primary outcome by 0.2 points.
Pinealon 10 mg
Longevity & Mitochondrial
The name says pineal. Zero papers link it to melatonin or sleep, and the one pineal-tissue experiment found it inactive. The neuron work is real.
PT-141 10 mg
Hormonal & Other
The only compound here with an approved counterpart — and the approval is the least flattering thing about it.
Retatrutide 10 mg
Metabolic & Weight
Lilly's LY3437943 — the most clinically advanced compound in this library, four Phase 3 trials reported.
Retatrutide 20 mg
Metabolic & Weight
Higher-fill vial of the same compound; fewer reconstitutions across a long protocol.
Selank 10 mg
Cognitive & Sleep
An over-the-counter anxiolytic in Russia — as nasal drops. Around 200 people studied, all open-label.
Semaglutide 5 / 10 mg
Metabolic & Weight
The one page here where the evidence is stronger than the marketing — which is exactly what makes a research vial of it indefensible.
Semax 10 mg
Cognitive & Sleep
A registered medicine in Russia — as nasal drops. Nothing injected has ever been studied.
Sermorelin 5 mg
Growth Hormone Axis
Approved as Geref, then withdrawn in 2009 — after losing head-to-head to growth hormone.
SLU-PP-332 5 mg
Metabolic & Weight
Pan-ERR agonist — an 'exercise mimetic' small molecule, not a peptide.
SS-31 10 mg
Longevity & Mitochondrial
FDA-approved Sept 2025 for Barth syndrome — having missed the primary endpoint of all seven controlled trials it ran.
Survodutide 10 mg
Metabolic & Weight
Phase 3 gave −13.0% at 76 weeks. It also lost 19% of participants to side effects, against 2.9% on placebo.
TB-500 10 mg
Repair & Recovery
Ac-LKKTETQ, the actin-binding region of thymosin β4 — note the identity caveat on the GLOW profile.
Tesamorelin 20 mg
Growth Hormone Axis
FDA-approved as Egrifta for HIV-associated lipodystrophy; the best-evidenced GHRH analogue.
Thymosin Alpha-1 10 mg
Immune & Anti-inflammatory
The largest sepsis trial ever run on it — 1,106 patients — found no benefit.
Tirzepatide 30 mg
Metabolic & Weight
The strongest evidence base here, and almost all of it surrogate. Its outcomes trial met non-inferiority against dulaglutide and failed superiority at p = 0.09.
Vilon 20 mg
Longevity & Mitochondrial
KE dipeptide, the thymic bioregulator of the Khavinson series.
Wolverine 20 mg
Blends & Stacks
Given together once, in four people, as two separate injections — and the combination arm did worse. Nobody has studied the premixed vial.
Nothing matches those filters. to see all 51 compounds.
51 compound profiles. 29 are linked to a product you can buy; 40 link through to a written profile so far, and the rest are being written. For laboratory research use only. Not for human or veterinary use.